codeine (Phenergan) Report issue

Small molecule Approved FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB

Active Ingredient History

NOW
  • Now
Codeine is an opiate used to manage mild to moderate pain severe enough to require an opioid. Codeine is a selective agonist for the mu opioid receptor and has an affinity to delta and kappa-opioid receptors. In some countries, this drug is regulated under various narcotic control laws, because its chronic use can cause physical dependence. In others, it is available without a medical prescription in combination with paracetamol.   NCATS

Chemistry

More Chemistry

Pharmacology

Drug Pricing (per unit)

Australia

$0.2132

United States

$0.5485 - $0.6651
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Combination drugs

( diphenhydramine (benadryl), codeine (Phenergan) )
|
( acetaminophen (tylenol), codeine (Phenergan) - other names: codrix, papa-deine, phenaphen w/ codeine , tylenol w/ codeine, tylenol w/ codeine )
|
( acetaminophen (tylenol), acetylsalicylic acid (aspirin), codeine (Phenergan) )
|
( acetaminophen (tylenol), caffeine, codeine (Phenergan), butalbital (fiornal) - other names: butalbital; acetaminophen; caffeine; codeine, phrenilin with caffeine and codeine )
|
( caffeine, acetylsalicylic acid (aspirin), codeine (Phenergan), butalbital (fiornal) )
|
( chlorpheniramine, codeine (Phenergan) - other names: codeprex, tuzistra xr )
|
( phenylephrine (Prefrin), promethazine hydrochloride (phenergan), codeine (Phenergan) - other names: pherazine vc w/ codeine, promethazine vc w/ codeine, prometh hydrochloride,phenylephrine hydrochloride w/codeine phosphate, prometh vc w/ codeine )
|
( promethazine hydrochloride (phenergan), codeine (Phenergan) - other names: pherazine w/ codeine, promethazine with codeine )
|
( carisoprodol (soma), acetylsalicylic acid (aspirin), codeine (Phenergan) )
|
( codeine (Phenergan), pseudoephedrine (Benylin), triprolidine (Actidil) )
|
( dexchlorpheniramine maleate (polaramine), codeine (Phenergan) )

Alternative names

3-methylmorphin | 3-methylmorphine | (5alpha,6alpha)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol | (5α,6α)-7,8-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate (ester) | (5α,6α)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol | 7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol | 7,8-didehydro-4,5α-epoxy-3-methoxy-17-methylmorphinan-6α-ol | 7,8-dihydro-4,5-alpha-epoxy-17-methylmorphinan-3,6-alpha-diol diacetate | ambenyl cough syrup | bepro | codein | codeína | codeine | (-)-codeine | (−)-codeine | codéine | codeine anhydrous | codeine monohydrate | codeine phosphate | codeine phosphate anhydrous | codeine phosphate hydrate | codeine polistirex | codeine sulfate | codeine sulfate trihydrate | codeinum | colrex compound | evacode | galcodine | ibuprofen codeine | l-codeine | methylmorphine | morphine 3-methyl ether | morphine-3-methyl ether | morphine monomethyl ether | n-methylmorphine | o(3)-methylmorphine

Organizations (154)

Research & Development (91)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (66)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (48)

Approved Indications (3)


 

Migraine Disorders

Pain

Spasm

Experimental Indications - Clinical Trial Phases 1-4 (46)


 

Abortion, Induced (Phase 4)

Analgesia (Phase 3)

Analgesics, Opioid (Phase 4)

Anemia, Sickle Cell (Phase 4)

Back Pain (Phase 4)

Breast Diseases (Phase 3)

Cervix Uteri (Phase 4)

Chronic Pain (Phase 4)

Cleft Lip (Phase 4)

Codeine (Phase 1)

Constipation (Phase 1)

Cough (Phase 1)

Depressive Disorder, Major (Phase 1)

Diabetic Neuropathies (Phase 1)

Esophageal Motility Disorders (Phase 4)

Fibromyalgia (Phase 1)

General Surgery (Phase 4)

Healthy Volunteers (Phase 1)

HIV Infections (Phase 3)

Hyperplasia (Phase 4)

Metabolism (Phase 1)

Metformin (Phase 1)

Musculoskeletal Pain (Phase 2)

Myopia (Phase 3)

Neck Pain (Phase 2)

Neonatology (Phase 1)

Neoplasms (Phase 4)

Nephrolithiasis (Phase 4)

Organic Cation Transporter 1 (Phase 1)

Osteoarthritis (Phase 4)

Pain ()

Pain, Postoperative (Phase 4)

Parathyroid Diseases (Phase 4)

Parathyroid Neoplasms (Phase 4)

Pharmacology (Phase 1)

Sports Medicine (Phase 1)

Stomach Diseases (Phase 4)

Temporomandibular Joint Disorders (Phase 4)

Thyroid Diseases (Phase 4)

Thyroid Gland (Phase 4)

Thyroid Neoplasms (Phase 4)

Thyroid Nodule (Phase 4)

Tonsillitis (Phase 4)

Tooth Abnormalities (Phase 4)

Vasomotor System (Phase 1)

Wounds and Injuries (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 79
  • # of Trial Organizations: 91

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue